Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Camprubí, Daniel, Almuedo-Riera, Alex, Martí-Soler, Helena, Soriano, Alex, Hurtado, Juan Carlos, Subirà, Carme, Grau-Pujol, Berta, Krolewiecki, Alejandro, Muñoz, Jose
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657540/
https://ncbi.nlm.nih.gov/pubmed/33175880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0242184
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados